Ocular Genetic Diagnostic Market, Global Outlook and Forecast 2024-2031

Report ID: 1659701 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Ocular Genetic Diagnostic Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Ocular Genetic Diagnostic Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Ocular Genetic Diagnostic Overall Market Size
    2.1 Global Ocular Genetic Diagnostic Market Size: 2021 VS 2028
    2.2 Global Ocular Genetic Diagnostic Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Ocular Genetic Diagnostic Players in Global Market
    3.2 Top Global Ocular Genetic Diagnostic Companies Ranked by Revenue
    3.3 Global Ocular Genetic Diagnostic Revenue by Companies
    3.4 Top 3 and Top 5 Ocular Genetic Diagnostic Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Ocular Genetic Diagnostic Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Ocular Genetic Diagnostic Players in Global Market
        3.6.1 List of Global Tier 1 Ocular Genetic Diagnostic Companies
        3.6.2 List of Global Tier 2 and Tier 3 Ocular Genetic Diagnostic Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Ocular Genetic Diagnostic Market Size Markets, 2021 & 2028
        4.1.2 Next-generation Sequencing (NGS)
        4.1.3 Multiplex Ligation-Dependent Probe Amplification (MLPA)
        4.1.4 Fragment Analysis PCR for Repeat Expansion Analysis
    4.2 By Type - Global Ocular Genetic Diagnostic Revenue & Forecasts
        4.2.1 By Type - Global Ocular Genetic Diagnostic Revenue, 2017-2022
        4.2.2 By Type - Global Ocular Genetic Diagnostic Revenue, 2023-2028
        4.2.3 By Type - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Ocular Genetic Diagnostic Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Diagnostic Laboratories
        5.1.4 Academic and Research Centers
        5.1.5 Others
    5.2 By Application - Global Ocular Genetic Diagnostic Revenue & Forecasts
        5.2.1 By Application - Global Ocular Genetic Diagnostic Revenue, 2017-2022
        5.2.2 By Application - Global Ocular Genetic Diagnostic Revenue, 2023-2028
        5.2.3 By Application - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Ocular Genetic Diagnostic Market Size, 2021 & 2028
    6.2 By Region - Global Ocular Genetic Diagnostic Revenue & Forecasts
        6.2.1 By Region - Global Ocular Genetic Diagnostic Revenue, 2017-2022
        6.2.2 By Region - Global Ocular Genetic Diagnostic Revenue, 2023-2028
        6.2.3 By Region - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Ocular Genetic Diagnostic Revenue, 2017-2028
        6.3.2 US Ocular Genetic Diagnostic Market Size, 2017-2028
        6.3.3 Canada Ocular Genetic Diagnostic Market Size, 2017-2028
        6.3.4 Mexico Ocular Genetic Diagnostic Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Ocular Genetic Diagnostic Revenue, 2017-2028
        6.4.2 Germany Ocular Genetic Diagnostic Market Size, 2017-2028
        6.4.3 France Ocular Genetic Diagnostic Market Size, 2017-2028
        6.4.4 U.K. Ocular Genetic Diagnostic Market Size, 2017-2028
        6.4.5 Italy Ocular Genetic Diagnostic Market Size, 2017-2028
        6.4.6 Russia Ocular Genetic Diagnostic Market Size, 2017-2028
        6.4.7 Nordic Countries Ocular Genetic Diagnostic Market Size, 2017-2028
        6.4.8 Benelux Ocular Genetic Diagnostic Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Ocular Genetic Diagnostic Revenue, 2017-2028
        6.5.2 China Ocular Genetic Diagnostic Market Size, 2017-2028
        6.5.3 Japan Ocular Genetic Diagnostic Market Size, 2017-2028
        6.5.4 South Korea Ocular Genetic Diagnostic Market Size, 2017-2028
        6.5.5 Southeast Asia Ocular Genetic Diagnostic Market Size, 2017-2028
        6.5.6 India Ocular Genetic Diagnostic Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Ocular Genetic Diagnostic Revenue, 2017-2028
        6.6.2 Brazil Ocular Genetic Diagnostic Market Size, 2017-2028
        6.6.3 Argentina Ocular Genetic Diagnostic Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Ocular Genetic Diagnostic Revenue, 2017-2028
        6.7.2 Turkey Ocular Genetic Diagnostic Market Size, 2017-2028
        6.7.3 Israel Ocular Genetic Diagnostic Market Size, 2017-2028
        6.7.4 Saudi Arabia Ocular Genetic Diagnostic Market Size, 2017-2028
        6.7.5 UAE Ocular Genetic Diagnostic Market Size, 2017-2028
7 Players Profiles
    7.1 Quest Diagnostics
        7.1.1 Quest Diagnostics Corporate Summary
        7.1.2 Quest Diagnostics Business Overview
        7.1.3 Quest Diagnostics Ocular Genetic Diagnostic Major Product Offerings
        7.1.4 Quest Diagnostics Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
        7.1.5 Quest Diagnostics Key News
    7.2 Columbia ophthalmology
        7.2.1 Columbia ophthalmology Corporate Summary
        7.2.2 Columbia ophthalmology Business Overview
        7.2.3 Columbia ophthalmology Ocular Genetic Diagnostic Major Product Offerings
        7.2.4 Columbia ophthalmology Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
        7.2.5 Columbia ophthalmology Key News
    7.3 Centogene
        7.3.1 Centogene Corporate Summary
        7.3.2 Centogene Business Overview
        7.3.3 Centogene Ocular Genetic Diagnostic Major Product Offerings
        7.3.4 Centogene Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
        7.3.5 Centogene Key News
    7.4 DBGen
        7.4.1 DBGen Corporate Summary
        7.4.2 DBGen Business Overview
        7.4.3 DBGen Ocular Genetic Diagnostic Major Product Offerings
        7.4.4 DBGen Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
        7.4.5 DBGen Key News
    7.5 Medgenome
        7.5.1 Medgenome Corporate Summary
        7.5.2 Medgenome Business Overview
        7.5.3 Medgenome Ocular Genetic Diagnostic Major Product Offerings
        7.5.4 Medgenome Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
        7.5.5 Medgenome Key News
    7.6 Sankara Nethralaya
        7.6.1 Sankara Nethralaya Corporate Summary
        7.6.2 Sankara Nethralaya Business Overview
        7.6.3 Sankara Nethralaya Ocular Genetic Diagnostic Major Product Offerings
        7.6.4 Sankara Nethralaya Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
        7.6.5 Sankara Nethralaya Key News
    7.7 Fulgent Genetics
        7.7.1 Fulgent Genetics Corporate Summary
        7.7.2 Fulgent Genetics Business Overview
        7.7.3 Fulgent Genetics Ocular Genetic Diagnostic Major Product Offerings
        7.7.4 Fulgent Genetics Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
        7.7.5 Fulgent Genetics Key News
    7.8 GeneDx
        7.8.1 GeneDx Corporate Summary
        7.8.2 GeneDx Business Overview
        7.8.3 GeneDx Ocular Genetic Diagnostic Major Product Offerings
        7.8.4 GeneDx Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
        7.8.5 GeneDx Key News
    7.9 Devyser
        7.9.1 Devyser Corporate Summary
        7.9.2 Devyser Business Overview
        7.9.3 Devyser Ocular Genetic Diagnostic Major Product Offerings
        7.9.4 Devyser Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
        7.9.5 Devyser Key News
    7.10 Invitae Corporation
        7.10.1 Invitae Corporation Corporate Summary
        7.10.2 Invitae Corporation Business Overview
        7.10.3 Invitae Corporation Ocular Genetic Diagnostic Major Product Offerings
        7.10.4 Invitae Corporation Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
        7.10.5 Invitae Corporation Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Ocular Genetic Diagnostic Market Opportunities & Trends in Global Market
    Table 2. Ocular Genetic Diagnostic Market Drivers in Global Market
    Table 3. Ocular Genetic Diagnostic Market Restraints in Global Market
    Table 4. Key Players of Ocular Genetic Diagnostic in Global Market
    Table 5. Top Ocular Genetic Diagnostic Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Ocular Genetic Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Ocular Genetic Diagnostic Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Ocular Genetic Diagnostic Product Type
    Table 9. List of Global Tier 1 Ocular Genetic Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Ocular Genetic Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Ocular Genetic Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Ocular Genetic Diagnostic Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Ocular Genetic Diagnostic Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Ocular Genetic Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Ocular Genetic Diagnostic Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Ocular Genetic Diagnostic Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Ocular Genetic Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Ocular Genetic Diagnostic Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Ocular Genetic Diagnostic Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Ocular Genetic Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Ocular Genetic Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Ocular Genetic Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Ocular Genetic Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Ocular Genetic Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 30. Quest Diagnostics Corporate Summary
    Table 31. Quest Diagnostics Ocular Genetic Diagnostic Product Offerings
    Table 32. Quest Diagnostics Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 33. Columbia ophthalmology Corporate Summary
    Table 34. Columbia ophthalmology Ocular Genetic Diagnostic Product Offerings
    Table 35. Columbia ophthalmology Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 36. Centogene Corporate Summary
    Table 37. Centogene Ocular Genetic Diagnostic Product Offerings
    Table 38. Centogene Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 39. DBGen Corporate Summary
    Table 40. DBGen Ocular Genetic Diagnostic Product Offerings
    Table 41. DBGen Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 42. Medgenome Corporate Summary
    Table 43. Medgenome Ocular Genetic Diagnostic Product Offerings
    Table 44. Medgenome Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 45. Sankara Nethralaya Corporate Summary
    Table 46. Sankara Nethralaya Ocular Genetic Diagnostic Product Offerings
    Table 47. Sankara Nethralaya Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 48. Fulgent Genetics Corporate Summary
    Table 49. Fulgent Genetics Ocular Genetic Diagnostic Product Offerings
    Table 50. Fulgent Genetics Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 51. GeneDx Corporate Summary
    Table 52. GeneDx Ocular Genetic Diagnostic Product Offerings
    Table 53. GeneDx Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 54. Devyser Corporate Summary
    Table 55. Devyser Ocular Genetic Diagnostic Product Offerings
    Table 56. Devyser Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 57. Invitae Corporation Corporate Summary
    Table 58. Invitae Corporation Ocular Genetic Diagnostic Product Offerings
    Table 59. Invitae Corporation Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Ocular Genetic Diagnostic Segment by Type in 2021
    Figure 2. Ocular Genetic Diagnostic Segment by Application in 2021
    Figure 3. Global Ocular Genetic Diagnostic Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Ocular Genetic Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Ocular Genetic Diagnostic Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Ocular Genetic Diagnostic Revenue in 2021
    Figure 8. By Type - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
    Figure 12. US Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
    Figure 16. Germany Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 17. France Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
    Figure 24. China Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 28. India Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
    Figure 30. Brazil Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
    Figure 33. Turkey Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 37. Quest Diagnostics Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Columbia ophthalmology Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Centogene Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. DBGen Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Medgenome Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Sankara Nethralaya Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Fulgent Genetics Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. GeneDx Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Devyser Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Invitae Corporation Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Ocular Genetic Diagnostic Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ocular Genetic Diagnostic Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ocular Genetic Diagnostic Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports